| LDR | 01098nam a22002771i 4500 | ||
| 001 | 000090753 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 880715s1978 mdu b f00010 eng d | ||
| 035 | ⊔ | ⊔ | ‡a(MiU)990000907530106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990000907530106381 |
| 035 | ⊔ | ⊔ | ‡asdr-umn000360836 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)3588277 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)160064049 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG3588277-B |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000090753 |
| 040 | ⊔ | ⊔ | ‡aDHEW ‡cDHEW ‡dCLU ‡dISUM ‡dMiU ‡dCStRLIN |
| 086 | ⊔ | ⊔ | ‡aII0 aHE 20.4208/2:An 8/7 |
| 110 | 1 | ⊔ | ‡aUnited States. ‡bFood and Drug Administration. ‡bBureau of Drugs. |
| 245 | 1 | 0 | ‡aGuidelines for the clinical evaluation of anti-inflammatory drugs (adults and children). |
| 260 | ⊔ | ⊔ | ‡aRockville, Md. : ‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, ‡c1977 i.e. 1978. |
| 300 | ⊔ | ⊔ | ‡aiii, 31 p. ; ‡c27 cm. |
| 490 | 0 | ⊔ | ‡aDHEW publication ; no. (FDA) 78-3054 |
| 490 | 0 | ⊔ | ‡aFDA Bureau of Drugs clinical guidelines |
| 500 | ⊔ | ⊔ | ‡aIncludes bibliographical references. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 2 | ‡aDrug Evaluation |
| 650 | ⊔ | 2 | ‡aAnti-Inflammatory Agents |
| 650 | ⊔ | 0 | ‡aAnti-inflammatory agents |
| 650 | ⊔ | 0 | ‡aDrugs ‡xTesting |
| CID | ⊔ | ⊔ | ‡a000090753 |
| DAT | 0 | ⊔ | ‡a19880715000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210928140712.0 ‡b2023-08-07T17:33:58Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990000907530106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015003204875 ‡sMIU ‡1990000907530106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230807 ‡sgoogle ‡umdp.39015003204875 ‡y1978 ‡rpd ‡qbib ‡tUS fed doc |
| 974 | ⊔ | ⊔ | ‡bUMN ‡cUMN ‡d20230316 ‡sgoogle ‡uumn.319510030512018 ‡y1978 ‡rpd ‡qbib ‡tUS fed doc |